High concentrations of plasma n3 fatty acids are associated with decreased risk for late age-related macular degeneration

Journal of Nutrition

Volumn 143, Issue 4, 2013, Pages 505-511

  Merle, Bénédicte M J ^a,b   Delyfer, Marie Noëlle ^a,b,c   Korobelnik, Jean François ^a,b,c   Rougier, Marie Bénédicte ^c   Malet, Florence ^c   Féart, Catherine ^a,b   Le Goff, Mélanie ^a,b   Peuchant, Evelyne ^a,c   Letenneur, Luc ^a,b   Dartigues, Jean François ^a,b   Colin, Joseph ^b,c   Barberger Gateau, Pascale ^a,b   Delcourt, Cécile ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; DNA POLYMORPHISM; EDUCATION; EYE EXAMINATION; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; GAS CHROMATOGRAPHY; GENDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL PHOTOGRAPHY; NUTRITION; OPTICAL COHERENCE TOMOGRAPHY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; FATTY ACIDS, OMEGA-3; FEMALE; FRANCE; HUMANS; LIPIDS; MACULAR DEGENERATION; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 84875770625     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.112.171033     Document Type: Article

References (57)

1. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379:1728-38.
2. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-36.
3. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83:S1467-76.
4. Anses. Actualisation des apports nutritionnels conseillés pour les acides gras; 2011 [cited 2012 Nov 28]. Available from: http://www.anses.fr/ Documents/NUT2006sa0359Ra.pdf.
5. Carrière I, Delcourt C, Lacroux A, Gerber M. Nutrient intake in an elderly population in southern France (POLANUT): deficiency in some vitamins, minerals and omega-3 PUFA. Int J Vitam Nutr Res. 2007;77:57-65.
6. Féart C, Jutand MA, Larrieu S, Letenneur L, Delcourt C, Combe N, Barberger-Gateau P. Energy, macronutrient and fatty acid intake of French elderly community dwellers and association with sociodemographic characteristics: data from the Bordeaux sample of the Three-City Study. Br J Nutr. 2007;98:1046-57.
7. Sioen IA, Pynaert I, Matthys C, De Backer G, Van Camp J, De Henauw S. Dietary intakes and food sources of fatty acids for Belgian women, focused on n-6 and n-3 polyunsaturated fatty acids. Lipids. 2006;41:415-22.
8. Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PR. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids. 2003;38:391-8.
9. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res. 2005;24:87-138.
10. Bazan NG. Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J Lipid Res. 2009;50 Suppl:S400-5.
11. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2006;51:137-52.
12. Delyfer MN, Buaud B, Korobelnik JF, Rougier MB, Schalch W, Etheve S, Vaysse C, Combe N, Goff ML, et al. Association of macular pigment density with plasma omega-3 fatty acids: the PIMAVOSA study. Invest Ophthalmol Vis Sci. 2012;53:1204-10.
13. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Dietary omega-3 fatty acid and fish intake in the primary prevention of agerelated macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol. 2008;126:826-33.
14. Chua B, Flood V, Rochtchina E, Wang JJ, Smith W, Mitchell P. Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch Ophthalmol. 2006;124:981-6.
15. Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, Seddon JM, Colditz GA, Hankinson SE. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr. 2001;73:209-18.
16. Arnarsson A, Sverrisson T, Stefansson E, Sigurdsson H, Sasaki H, Sasaki K, Jonasson F. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. Am J Ophthalmol. 2006;142: 419-28.
17. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, Willett W. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol. 2001;119:1191-9.
18. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol. 2006;124:995-1001.
19. SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL III, Gensler GR, Kurinij N, Lindblad AS, Milton RC, et al. The relationship of dietary lipid intake and age-related macular degeneration in a casecontrol study: AREDS Report No. 20. Arch Ophthalmol. 2007;125: 671-9.
20. Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M. Dietary fat and age-related maculopathy. Arch Ophthalmol. 1995;113:743-8.
21. Heuberger RA, Mares-Perlman JA, Klein R, Klein BE, Millen AE, Palta M. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Arch Ophthalmol. 2001;119:1833-8.
22. Delcourt C, Carriere I, Cristol JP, Lacroux A, Gerber M. Dietary fat and the risk of age-related maculopathy: the POLANUT study. Eur J Clin Nutr. 2007;61:1341-4.
23. Robman L, Vu H, Hodge A, Tikellis G, Dimitrov P, McCarty C, Guymer R. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can J Ophthalmol. 2007;42:720-6.
24. Augood C, Chakravarthy U, Young I, Vioque J, de Jong PT, Bentham G, Rahu M, Seland J, Soubrane G, et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr. 2008;88:398-406.
25. SanGiovanni JP, Chew EY, Agron E, Clemons TE, Ferris FL III, Gensler G, Lindblad AS, Milton RC, Seddon JM, et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol. 2008;126:1274-9.
26. Tan JS,Wang JJ, Flood V, Mitchell P. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol. 2009;127:656-65.
27. SanGiovanni JP, Agron E, Clemons TE, Chew EY. Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration. Arch Ophthalmol. 2009;127:110-2.
28. Parekh N, Voland RP, Moeller SM, Blodi BA, Ritenbaugh C, Chappell RJ, Wallace RB, Mares JA. Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative. Arch Ophthalmol. 2009;127:1483-93.
29. Merle B, Delyfer MN, Korobelnik JF, Rougier MB, Colin J, Malet F, Feart C, Le Goff M, Dartigues JF, et al. Dietary omega-3 fatty acids and the risk for age-related maculopathy: the Alienor Study. Invest Ophthalmol Vis Sci. 2011;52:6004-11.
30. Christen WG, Schaumberg DA, Glynn RJ, Buring JE. Dietary omega-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch Ophthalmol. 2011;129:921-9.
31. Swenor BK, Bressler S, Caulfield L, West SK. The impact of fish and shellfish consumption on age-related macular degeneration. Ophthalmology. 2010;117:2395-401.
32. Serra-Majem L, Nissensohn M, Overby NC, Fekete K. Dietary methods and biomarkers of omega 3 fatty acids: a systematic review. Br J Nutr. 2012;107 Suppl 2:S64-76.
33. Féart C, Peuchant E, Letenneur L, Samieri C, Montagnier D, Fourrier- Reglat A, Barberger-Gateau P. Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. Am J Clin Nutr. 2008;87:1156-62.
34. Samieri C, Feart C, Letenneur L, Dartigues JF, Peres K, Auriacombe S, Peuchant E, Delcourt C, Barberger-Gateau P. Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr. 2008;88:714-21.
35. Wilk JB, Tsai MY, Hanson NQ, Gaziano JM, Djousse L. Plasma and dietary omega-3 fatty acids, fish intake, and heart failure risk in the Physicians' Health Study. Am J Clin Nutr. 2012;96:882-8.
36. Kröger E, Verreault R, Carmichael PH, Lindsay J, Julien P, Dewailly E, Ayotte P, Laurin D. Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am J Clin Nutr. 2009;90:184-92.
37. Djoussé L, Biggs ML, Lemaitre RN, King IB, Song X, Ix JH, Mukamal KJ, Siscovick DS, Mozaffarian D. Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr. 2011;94:527-33.
38. Delcourt C, Korobelnik JF, Barberger-Gateau P, DelyferMN, Rougier MB, Le Goff M, Malet F, Colin J, Dartigues JF. Nutrition and age-related eye diseases: the Alienor (Antioxydants, Lipides Essentiels, Nutrition et maladies OculaiRes) Study. J Nutr Health Aging. 2010;14:854-61.
39. 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology. 2003;22:316-25.
40. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367-74.
41. Peuchant E, Wolff R, Salles C, Jensen R. One-step extraction of human erythrocyte lipids allowing rapid determination of fatty acid composition. Anal Biochem. 1989;181:341-4.
42. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009;41:1094-9.
43. Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, Boekhoorn SS, Vingerling JR, Hofman A, et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006;296:301-9.
44. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049-60.
45. Delcourt C, Delyfer MN, Rougier MB, Amouyel P, Colin J, Le Goff M, Malet F, Dartigues JF, Lambert JC, Korobelnik JF. Associations of complement factor H and smoking with early age-related macular degeneration: the ALIENOR study. Invest Ophthalmol Vis Sci. 2011;52:5955-62.
46. Delcourt C, Delyfer MN, Rougier MB, Lambert JC, Amouyel P, Colin J, Malet F, Le Goff M, Dartigues JF, Korobelnik JF. ARMS2 A69S polymorphism and the risk for age-related maculopathy: The ALIENOR Study. Arch Ophthalmol. 2012;130:1077-8.
47. Arab L. Biomarkers of fat and fatty acid intake. J Nutr. 2003;133 Suppl 3:S925-32.
48. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, de Jong PT. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205-10.
49. Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Bentham G, et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol. 2006;124:529-35.
50. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122: 564-72.
51. Delcourt C, Lacroux A, Carriere I. The three-year incidence of agerelated macular degeneration: the "Pathologies Oculaires Liees a l'Age'' (POLA) prospective study. Am J Ophthalmol. 2005;140: 924-6.
52. Klaver CC, Assink JJ, van Leeuwen R, Wolfs RC, Vingerling JR, Stijnen T, Hofman A, de Jong PT. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2001;42:2237-41.
53. Wolf S, Wolf-Schnurrbusch U. Spectral-domain optical coherence tomography use in macular diseases: a review. Ophthalmologica. 2010;224:333-40.
54. Millen AE, Voland R, Sondel SA, Parekh N, Horst RL, Wallace RB, Hageman GS, Chappell R, Blodi BA, et al. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol. 2011;129:481-9.
55. Parekh N, Chappell RJ, Millen AE, Albert DM, Mares JA. Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol. 2007;125:661-9.
56. Wang JJ, Rochtchina E, Smith W, Klein R, Klein BE, Joshi T, Sivakumaran TA, Iyengar S, Mitchell P. Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort. Am J Epidemiol. 2009;169:633-41.
57. Chew EY, Clemons T, Sangiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris FL. The Age-related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report Number 1). Ophthalmology. 2012;119:2282-9.